• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: I-SENS, INC. ASSURE PRISM BLOOD GLUCOSE TEST SYSTEM; SYSTEM, TEST, BLOOD GLUCOSE, OVER THE COUNTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

I-SENS, INC. ASSURE PRISM BLOOD GLUCOSE TEST SYSTEM; SYSTEM, TEST, BLOOD GLUCOSE, OVER THE COUNTER Back to Search Results
Model Number 530001
Medical Device Problem Code Low Readings (2460)
Health Effect - Clinical Codes Hyperglycemia (1905); Elevated ketones/Diabetic Ketoacidosis (2364)
Date of Event 02/23/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Meter and strips involved in incident were returned for investigation, evaluated, and tested.Products performed to specification.No failure detected.Products will be forwarded to manufacturer.
 
Event or Problem Description
Customer had sent an email stating that the glucose monitors are reading several points off from the hospital readings.When this begins to happen (after about six months of use) we end up replacing them.As recently as last week, we had a reading of 300, our local fire department had a reading of 500, and the hospital obtained a reading of 1100.This was a critical patient in diabetic ketoacidosis who required intubation.Arkray followed up with customer by phone.Verified the readings were within 20 minutes of each other.Customer stores meter and test strips together in the ambulance in a medical bag in the back of the ambulance.Meters are stored in a temperature-controlled environment of 68-72 degrees.Customer said that the incident occurred on (b)(6) 2024 at about 10:33 pm.They received a call that a patient was unresponsive.Ems arrived at the patient's home, took her glucose reading and gave her oxygen.Patient takes novolog and victoza for type 2 diabetes.She doesn't use oxygen normally but was given oxygen upon arrival at her home.Verified that customer seals the test strip bottle immediately after removing a strip.Verified they used alcohol to clean the patient's fingers, used a new sterile lancet, and they wiped away the first drop then used the second drop of blood to test.They used a fresh sample of capillary blood from the fingertip.The patient was transported to the hospital.The patient was hypotensive and was given epinephrine.The patient is still alive.Replaced meter, strips and sent return label.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ASSURE PRISM BLOOD GLUCOSE TEST SYSTEM
Common Device Name
SYSTEM, TEST, BLOOD GLUCOSE, OVER THE COUNTER
Manufacturer (Section D)
I-SENS, INC.
43, banpo-daero 28-gil
seocho-gu
seoul, 06646
KS  06646
MDR Report Key18931638
Report Number1832816-2024-00007
Device Sequence Number21173339
Product Code NBW
UDI-Device Identifier00015482530013
UDI-Public(01)00015482530013
Combination Product (Y/N)N
Initial Reporter StateOH
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Importer
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 03/11/2024
Report Date (Section F) 03/19/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date08/24/2025
Device Model Number530001
Device Catalogue Number530001
Device Lot NumberWL27MAM7B
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/11/2024
Was the Report Sent to FDA? Yes
Distributor Facility Aware Date02/26/2024
Event Location Home
Date Report to Manufacturer03/19/2024
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date03/19/2024
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Life Threatening; Required Intervention; Hospitalization;
Patient Age73 YR
Patient SexFemale
Date Report Sent to FDA03/19/2024
-
-